Form 4 for INM InMed Pharmaceuticals Inc.
Accepted 2021-09-30 00:00:00 ET · period of report 2021-09-29 · accession 0001213900-21-050751 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-09-30 | 2021-09-29 | INM | ADAMS ERIC A | Pres, CEO, Dir | P - Purchase | $1.73 | +8,800 | 36.3K | +32% | +$15.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-29 | P | A | 8,800 | $1.73 | 36,283 | D | — | — |